• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本两百万公共援助受助人中按年龄、性别和地域划分的 2 型糖尿病患病率:使用全国代表性理赔数据库的横断面研究。

Prevalence of type 2 diabetes by age, sex and geographical area among two million public assistance recipients in Japan: a cross-sectional study using a nationally representative claims database.

机构信息

Department of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan

Human Care Research Team, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo, Japan.

出版信息

J Epidemiol Community Health. 2022 Apr;76(4):391-397. doi: 10.1136/jech-2020-216158. Epub 2021 Oct 28.

DOI:10.1136/jech-2020-216158
PMID:34711673
Abstract

BACKGROUND

Recognising the importance of the social determinants of health, the Japanese government introduced a health management support programme targeted at type 2 diabetes (T2D) for public assistance recipients (PAR) in 2018. However, evidence of the T2D prevalence among PAR is lacking. We aimed to estimate T2D prevalence by age and sex among PAR, compared with the prevalence among health insurance enrollees (HIE). Additionally, regional differences in T2D prevalence among PAR were examined.

METHODS

This was a cross-sectional study using 1-month health insurance claims of both PAR and HIE. The Fact-finding Survey data on Medical Assistance and the National Database of Health Insurance Claims data were used. T2D prevalence among PAR and HIE were assessed by age and sex, respectively. Moreover, to examine regional differences in T2D prevalence of inpatients and outpatients among PAR, T2D crude prevalence and age-standardised prevalence were calculated by prefecture. Multilevel logistic regression analysis was also conducted at the city level.

RESULTS

T2D crude prevalence was 7.7% in PAR (inpatients and outpatients). Among outpatients, the prevalence was 7.5% in PAR and 4.1% in HIE, respectively. The mean crude prevalence and age-standardised prevalence of T2D (inpatients and outpatients) among 47 prefectures were 7.8% and 3.9%, respectively. In the city-level analysis, the OR for the prevalence of T2D by region ranged from 0.31 to 1.51.

CONCLUSION

The prevalence of T2D among PAR was higher than HIE and there were regional differences in the prevalence of PAR. Measures to prevent the progression of diabetes among PAR by region are needed.

摘要

背景

认识到健康的社会决定因素的重要性,日本政府于 2018 年为公共援助受助人(PAR)推出了一项针对 2 型糖尿病(T2D)的健康管理支持计划。然而,缺乏 PAR 中 T2D 患病率的证据。我们旨在估计 PAR 中 T2D 的年龄和性别患病率,并与健康保险参保人(HIE)的患病率进行比较。此外,还检查了 PAR 中 T2D 患病率的地区差异。

方法

这是一项使用 PAR 和 HIE 为期一个月的健康保险索赔的横断面研究。使用了《医疗援助事实调查数据》和《国家健康保险索赔数据库》的数据。PAR 和 HIE 中 T2D 的患病率分别按年龄和性别进行评估。此外,为了检查 PAR 中住院和门诊患者 T2D 患病率的地区差异,按县计算了 T2D 的粗患病率和年龄标准化患病率。还在市级水平进行了多水平逻辑回归分析。

结果

PAR 中的 T2D 粗患病率为 7.7%(住院和门诊)。在门诊患者中,PAR 的患病率为 7.5%,HIE 的患病率为 4.1%。47 个县的 T2D(住院和门诊)的平均粗患病率和年龄标准化患病率分别为 7.8%和 3.9%。在市级分析中,T2D 患病率的地区比值比范围为 0.31 至 1.51。

结论

PAR 中 T2D 的患病率高于 HIE,并且 PAR 的患病率存在地区差异。需要采取措施,根据地区情况,预防 PAR 中糖尿病的进展。

相似文献

1
Prevalence of type 2 diabetes by age, sex and geographical area among two million public assistance recipients in Japan: a cross-sectional study using a nationally representative claims database.日本两百万公共援助受助人中按年龄、性别和地域划分的 2 型糖尿病患病率:使用全国代表性理赔数据库的横断面研究。
J Epidemiol Community Health. 2022 Apr;76(4):391-397. doi: 10.1136/jech-2020-216158. Epub 2021 Oct 28.
2
Type 2 diabetes in the employed population: do rates and trends differ among nine occupational sectors? An analysis using German health insurance claims data.就业人群中的 2 型糖尿病:九个职业领域的发病率和趋势是否存在差异?利用德国健康保险索赔数据进行的分析。
BMC Public Health. 2024 May 3;24(1):1231. doi: 10.1186/s12889-024-18705-5.
3
Geographical Variation in Psychiatric Admissions Among Recipients of Public Assistance.接受公共援助的人群中的精神科住院治疗的地域差异。
J Epidemiol. 2019 Jul 5;29(7):264-271. doi: 10.2188/jea.JE20180066. Epub 2018 Sep 22.
4
Decreasing incidence of type 2 diabetes mellitus in the United States, 2007-2012: Epidemiologic findings from a large US claims database.2007 - 2012年美国2型糖尿病发病率下降:来自美国一个大型理赔数据库的流行病学研究结果
Diabetes Res Clin Pract. 2016 Jul;117:111-8. doi: 10.1016/j.diabres.2016.04.043. Epub 2016 Apr 30.
5
Estimating diabetes mellitus incidence using health insurance claims data: A database-driven cohort study.利用医疗保险理赔数据估算糖尿病发病率:一项基于数据库的队列研究。
PLoS One. 2024 Oct 2;19(10):e0311517. doi: 10.1371/journal.pone.0311517. eCollection 2024.
6
Prevalence of diabetes in Northern African countries: the case of Tunisia.北非国家糖尿病患病率:以突尼斯为例。
BMC Public Health. 2014 Jan 28;14:86. doi: 10.1186/1471-2458-14-86.
7
National type 2 diabetes prevention programme in Finland: FIN-D2D.芬兰全国2型糖尿病预防计划:FIN-D2D。
Int J Circumpolar Health. 2007 Apr;66(2):101-12. doi: 10.3402/ijch.v66i2.18239.
8
Public assistance program and depressive symptoms of the recipient: a cross-sectional Japan Gerontological Evaluation Study.公共援助计划与受助人的抑郁症状:一项日本老年学评估研究的横断面研究。
BMC Geriatr. 2022 Mar 3;22(1):177. doi: 10.1186/s12877-022-02868-0.
9
Prevalence of Metabolic Syndrome in Patients with Type 2 Diabetes in Japan: A Retrospective Cross-Sectional Study.日本2型糖尿病患者代谢综合征的患病率:一项回顾性横断面研究。
Diabetes Ther. 2024 Jan;15(1):245-256. doi: 10.1007/s13300-023-01484-4. Epub 2023 Oct 19.
10
Factors associated with consulting a dietitian for diabetes management: a cross-sectional study.与糖尿病管理相关的咨询营养师的因素:一项横断面研究。
BMC Health Serv Res. 2013 Dec 5;13:504. doi: 10.1186/1472-6963-13-504.

引用本文的文献

1
Community-level social capital and polypharmacy among public assistance recipients in Japan: A multilevel cross-sectional study.日本公共援助受助者的社区层面社会资本与多重用药:一项多层次横断面研究。
SSM Popul Health. 2025 Mar 20;30:101788. doi: 10.1016/j.ssmph.2025.101788. eCollection 2025 Jun.
2
Diabetes control in public assistance recipients and free/low-cost medical care program beneficiaries in Japan: a retrospective cross-sectional study.日本公共援助受助者及免费/低成本医疗保健计划受益人的糖尿病控制情况:一项回顾性横断面研究。
BMJ Public Health. 2024 May 30;2(1):e000686. doi: 10.1136/bmjph-2023-000686. eCollection 2024 Jun.
3
Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes.
阿法依鲁肽在健康受试者和2型糖尿病受试者中的群体药代动力学
Clin Pharmacokinet. 2025 Apr;64(4):533-552. doi: 10.1007/s40262-025-01475-7. Epub 2025 Feb 17.
4
Health Statuses of People in Poverty Receiving Public Assistance in Japan: A Scoping Review.日本接受公共援助的贫困人口的健康状况:一项范围综述。
JMA J. 2024 Jul 16;7(3):301-312. doi: 10.31662/jmaj.2024-0062. Epub 2024 Jun 28.
5
Survival Time Disparities after Palliative Care Use Among Low-Income Patients on Social Welfare Programs: A Retrospective Cohort Study.社会福利项目中低收入患者接受姑息治疗后的生存时间差异:一项回顾性队列研究
Palliat Med Rep. 2024 May 15;5(1):187-193. doi: 10.1089/pmr.2023.0077. eCollection 2024.
6
Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model.使用基于生理的药代动力学模型评估日本和欧洲血统受试者中替格列汀药代动力学的年龄相关变化。
Diabetes Ther. 2024 Apr;15(4):763-777. doi: 10.1007/s13300-023-01514-1. Epub 2023 Dec 20.
7
Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post-hoc analysis of two randomized, placebo-controlled trials.患者特征对日本 2 型糖尿病患者单用伊美格鲁肽疗效和安全性的影响:两项随机、安慰剂对照试验的事后分析。
J Diabetes Investig. 2023 Sep;14(9):1101-1109. doi: 10.1111/jdi.14035. Epub 2023 Jun 1.
8
Changes in health-related quality of life scores among low-income patients on social welfare programs in Japan during the COVID-19 pandemic: a single-center repeated cross-sectional study.在 COVID-19 大流行期间,日本社会福利计划中低收入患者健康相关生活质量评分的变化:一项单中心重复横断面研究。
BMC Public Health. 2022 Nov 22;22(1):2147. doi: 10.1186/s12889-022-14597-5.
9
Alterations in epidermal function in type 2 diabetes: Implications for the management of this disease.2 型糖尿病患者表皮功能的改变:对这种疾病管理的影响。
J Diabetes. 2022 Sep;14(9):586-595. doi: 10.1111/1753-0407.13303. Epub 2022 Aug 31.